Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human EARS2 Protein, N-His

Catalog #:   YHK00901 Specific References (27) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q5JPH6
Protein length: Gly247-Gln496
Overview

Catalog No.

YHK00901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gly247-Gln496

Predicted molecular weight

30.51 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q5JPH6

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

KIAA1970, Glutamyl-tRNA synthetase, EARS2, Probable glutamate--tRNA ligase, mitochondrial, GluRS

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human EARS2 protein
References

B cell dysfunction in thalamus and brainstem involvement and high lactate caused by novel mutation of EARS2 gene., PMID:40389993

Identification of EARS2 as a Potential Biomarker with Diagnostic, Prognostic, and Therapeutic Implications in Colorectal Cancer., PMID:39906030

Phenotyping mitochondrial glutamyl-tRNA synthetase deficiency (EARS2): A case series and systematic literature review., PMID:39173847

Proteomic-based stratification of intermediate-risk prostate cancer patients., PMID:38052461

Mitochondrial aminoacyl-tRNA synthetases trigger unique compensatory mechanisms in neurons., PMID:37975900

Neuropathological hallmarks of antenatal mitochondrial diseases with a corpus callosum defect., PMID:36349561

EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer., PMID:35779338

The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection., PMID:35153822

Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations., PMID:33972171

Remitting and exacerbating white matter lesions in leukoencephalopathy with thalamus and brainstem involvement and high lactate., PMID:33962821

Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma., PMID:33833525

Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency., PMID:33128823

Identification of a Novel Variant in EARS2 Associated with a Severe Clinical Phenotype Expands the Clinical Spectrum of LTBL., PMID:32887222

Roles of BdUNICULME4 and BdLAXATUM-A in the non-domesticated grass Brachypodium distachyon., PMID:32343459

Mutations in aARS genes revealed by targeted next-generation sequencing in patients with mitochondrial diseases., PMID:32319008

Phenotypes and genotypes of mitochondrial aminoacyl-tRNA synthetase deficiencies from a single neurometabolic clinic., PMID:32071833

Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination., PMID:31839000

The genomic and clinical landscape of fetal akinesia., PMID:31680123

Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations., PMID:29410512

Functionally pathogenic EARS2 variants in vitro may not manifest a phenotype in vivo., PMID:28748214

Severe Metabolic Acidosis and Hepatopathy due to Leukoencephalopathy with Thalamus and Brainstem Involvement and High Lactate., PMID:27875839

Lethal Neonatal LTBL Associated with Biallelic EARS2 Variants: Case Report and Review of the Reported Neuroradiological Features., PMID:27571996

Leukoencephalopathy with thalamus and brainstem involvement and high lactate caused by novel mutations in the EARS2 gene in two siblings., PMID:27206875

A compound heterozygous EARS2 mutation associated with mild leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL)., PMID:27117034

Early-Onset Mild Type Leukoencephalopathy Caused by a Homozygous EARS2 Mutation., PMID:26893310

EARS2 mutations cause fatal neonatal lactic acidosis, recurrent hypoglycemia and agenesis of corpus callosum., PMID:26780086

Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations., PMID:22492562

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human EARS2 Protein, N-His [YHK00901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only